- Home
- PLPC vs TERN Comparison
PLPC vs TERN Comparison
Compare PLPC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLPC
- TERN
- Stock Information
- Founded
- PLPC 1947
- TERN 2017
- Country
- PLPC United States
- TERN United States
- Employees
- PLPC N/A
- TERN N/A
- Industry
- PLPC Water Sewer Pipeline Comm & Power Line Construction
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- PLPC Industrials
- TERN Health Care
- Exchange
- PLPC Nasdaq
- TERN Nasdaq
- Market Cap
- PLPC 671.9M
- TERN 586.0M
- IPO Year
- PLPC N/A
- TERN 2021
- Fundamental
- Price
- PLPC $132.59
- TERN $6.17
- Analyst Decision
- PLPC
- TERN Buy
- Analyst Count
- PLPC 0
- TERN 6
- Target Price
- PLPC N/A
- TERN $16.42
- AVG Volume (30 Days)
- PLPC 9.9K
- TERN 1.3M
- Earning Date
- PLPC 10-30-2024
- TERN 11-12-2024
- Dividend Yield
- PLPC 0.60%
- TERN N/A
- EPS Growth
- PLPC N/A
- TERN N/A
- EPS
- PLPC 6.65
- TERN N/A
- Revenue
- PLPC $572,200,000.00
- TERN N/A
- Revenue This Year
- PLPC N/A
- TERN N/A
- Revenue Next Year
- PLPC N/A
- TERN N/A
- P/E Ratio
- PLPC $20.17
- TERN N/A
- Revenue Growth
- PLPC N/A
- TERN N/A
- 52 Week Low
- PLPC $109.01
- TERN $3.59
- 52 Week High
- PLPC $142.91
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- PLPC 61.87
- TERN 31.82
- Support Level
- PLPC $135.35
- TERN $6.99
- Resistance Level
- PLPC $142.91
- TERN $7.53
- Average True Range (ATR)
- PLPC 3.37
- TERN 0.47
- MACD
- PLPC 0.88
- TERN -0.02
- Stochastic Oscillator
- PLPC 75.31
- TERN 16.57
About PLPC Preformed Line Products Company
Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. In addition, it provides solar hardware systems and mounting hardware for a variety of solar power applications. Its products consist of Energy Products, Communications Products, and Special Industries Products. The company's majority of the revenue is derived from the sale of products in The Americas with operations also in PLP-USA, Europe, the Middle East and Africa, and Asia-Pacific. The revenue gets driven by Energy products which comprise protecting transmission conductors, spacers, spacer-dampers, and Stockbridge dampers.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.